153 related articles for article (PubMed ID: 38515317)
1. The relationship between hematologic malignancies on male hypogonadism: a scoping review.
Roth B; Moukhtar Hammad MA; Sanford DI; Piper M; Barham DW; Yafi FA; Jenkins LC
Sex Med Rev; 2024 Mar; ():. PubMed ID: 38515317
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. B-cell maturation antigen expression across hematologic cancers: a systematic literature review.
Dogan A; Siegel D; Tran N; Fu A; Fowler J; Belani R; Landgren O
Blood Cancer J; 2020 Jun; 10(6):73. PubMed ID: 32606424
[TBL] [Abstract][Full Text] [Related]
4. Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Grant SJ; Grimshaw AA; Silberstein J; Murdaugh D; Wildes TM; Rosko AE; Giri S
Transplant Cell Ther; 2022 Jun; 28(6):294-302. PubMed ID: 35288347
[TBL] [Abstract][Full Text] [Related]
5. A Scoping Review of Otologic Manifestations of Hematologic Malignancies.
Raymond MJ; Ottinger A; Rowley MA; Bobian M; Dornhoffer J; Brennan E; Rizk HG
Otol Neurotol; 2024 Apr; 45(4):362-375. PubMed ID: 38437804
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies.
Saiz LC; Leache L; Gutiérrez-Valencia M; Erviti J; Rojas Reyes MX
Ther Adv Hematol; 2023; 14():20406207231168211. PubMed ID: 37138698
[TBL] [Abstract][Full Text] [Related]
7. Symptom experiences of critically-ill hematologic malignancy patients: A scoping review.
Moore JE; Munshi L; Mayo SJ; Armstrong G; Dale CM
Intensive Crit Care Nurs; 2022 Jun; 70():103187. PubMed ID: 35125312
[TBL] [Abstract][Full Text] [Related]
8. Nationwide analysis of adult hospitalizations with hematologic malignancies and systemic sclerosis.
Romero Noboa ME; Litvin R; Sami F; Tanveer S
ARP Rheumatol; 2023; 2(4):291-298. PubMed ID: 38174748
[TBL] [Abstract][Full Text] [Related]
9. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
10. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.
Ohbiki M; Ito Y; Inamoto Y; Miyamura K; Uchida N; Fukuda T; Fujiwara H; Nishida T; Hayashi M; Tanaka M; Kawakita T; Ikegame K; Katayama Y; Ara T; Ichinohe T; Kiyoi H; Matsuo K; Atsuta Y
Transplant Cell Ther; 2023 Dec; 29(12):768.e1-768.e10. PubMed ID: 37739224
[TBL] [Abstract][Full Text] [Related]
11. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
12. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.
Margolin K; Forman SJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S33-8. PubMed ID: 10685656
[TBL] [Abstract][Full Text] [Related]
14. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
Boyiadzis M; Bishop MR; Abonour R; Anderson KC; Ansell SM; Avigan D; Barbarotta L; Barrett AJ; Van Besien K; Bergsagel PL; Borrello I; Brody J; Brufsky J; Cairo M; Chari A; Cohen A; Cortes J; Forman SJ; Friedberg JW; Fuchs EJ; Gore SD; Jagannath S; Kahl BS; Kline J; Kochenderfer JN; Kwak LW; Levy R; de Lima M; Litzow MR; Mahindra A; Miller J; Munshi NC; Orlowski RZ; Pagel JM; Porter DL; Russell SJ; Schwartz K; Shipp MA; Siegel D; Stone RM; Tallman MS; Timmerman JM; Van Rhee F; Waller EK; Welsh A; Werner M; Wiernik PH; Dhodapkar MV
J Immunother Cancer; 2016; 4():90. PubMed ID: 28018601
[TBL] [Abstract][Full Text] [Related]
15. Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy.
Kiserud CE; Fosså A; Bjøro T; Holte H; Cvancarova M; Fosså SD
Br J Cancer; 2009 Feb; 100(3):455-63. PubMed ID: 19156143
[TBL] [Abstract][Full Text] [Related]
16. Impact of Influenza Infection Among Adult and Pediatric Populations With Hematologic Malignancy and Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis.
Atalla E; Kalligeros M; Mylona EK; Tsikala-Vafea M; Shehadeh F; Georgakas J; Mylonakis E
Clin Ther; 2021 May; 43(5):e66-e85. PubMed ID: 33812700
[TBL] [Abstract][Full Text] [Related]
17. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Freireich EJ; Keating M; Cabanillas F; Barlogie B
Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
[TBL] [Abstract][Full Text] [Related]
18. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
20. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.
Leifke E; Körner HC; Link TM; Behre HM; Peters PE; Nieschlag E
Eur J Endocrinol; 1998 Jan; 138(1):51-8. PubMed ID: 9461316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
